Crispr Therapeutics Ag (CRSP)

$54.88 +0.75 (1.39%)
Market Cap 4.92B
Revenue (ttm) 37.31M
Net Income (ttm) -366.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -981.64%
Debt to Equity Ratio 0.00
Volume 1,278,100
Avg Vol 3,507,342
Day's Range N/A - N/A
Shares Out 90.95M
Stochastic %K 32%
Beta 1.80
Analysts Sell
Price Target $80.83

Company Profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 41 561 32 77
Address:
Baarerstrasse 14, Zug, Switzerland
shashg
shashg Aug. 27 at 2:30 AM
$ABBV $CRSP $TDOC
1 · Reply
NwordFslur
NwordFslur Aug. 27 at 2:24 AM
$CRSP traumatized by $VKTX, still sticking with CRSP but with shaky hands
0 · Reply
IBott
IBott Aug. 27 at 1:51 AM
$CRSP 165,000 plus more shares bought today by ARK. She can’t stop!
0 · Reply
DimebagDarrell_
DimebagDarrell_ Aug. 26 at 8:23 PM
$CRBU Detached from $CRSP now. Let’s roll.
0 · Reply
BillyBlanks77
BillyBlanks77 Aug. 26 at 7:46 PM
$CRSP Like clockwork. The shorts knock it down at the close on a light volume day. I do think we are due for a 10+% up day with some covering soon...
1 · Reply
AlphaByAI
AlphaByAI Aug. 26 at 6:27 PM
$ABBV $CRSP $TDOC Deep dive in three longevity and aging related stocks. https://newsletter.ai-wk.com/p/longevity-aging-watchlist-abbv-crsp-tdoc
0 · Reply
HodlTurtle
HodlTurtle Aug. 26 at 5:53 PM
$CRSP imagine shorting at the lows after two major insider purchases and institutions stacking at the dips. Who could possibly be that stupid 😂
0 · Reply
svertical1
svertical1 Aug. 26 at 5:22 PM
$IBRX $CADL $CRSP The battle lines are drawn: •On one side, the scum ruthlessly doing everything to protect the decades long monopoly of inevitable failure with chemo & radiation. •Others doing everything to actually make progress towards a cure without destroying a patients natural immunity
2 · Reply
Malachi_Constant
Malachi_Constant Aug. 26 at 4:07 PM
$CRSP every daytrader thinks he's Jeremy Irons in Margin Call. "This is it!" https://www.youtube.com/watch?v=UOYi4NzxlhE
0 · Reply
dileep1209
dileep1209 Aug. 26 at 3:36 PM
$CRSP https://seekingalpha.com/article/4816385-crispr-therapeutics-sell-before-too-late
0 · Reply
Latest News on CRSP
Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

Aug 14, 2025, 1:02 PM EDT - 12 days ago

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

AMD ARKF ARKG ARKK ARKQ ARKW ARKX

Upgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025

Aug 14, 2025, 7:27 AM EDT - 12 days ago

Upgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 4:15 PM EDT - 22 days ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big

Jul 23, 2025, 11:03 AM EDT - 4 weeks ago

Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big

The Big 3: ASML, GOOGL, CRSP

Jul 15, 2025, 12:01 PM EDT - 6 weeks ago

The Big 3: ASML, GOOGL, CRSP

ASML GOOG GOOGL

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

Jul 14, 2025, 8:00 AM EDT - 6 weeks ago

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Jun 26, 2025, 7:00 AM EDT - 2 months ago

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

The Big 3: CRSP, OKLO, GME

Jun 23, 2025, 12:01 PM EDT - 2 months ago

The Big 3: CRSP, OKLO, GME

OKLO GME

Crispr Therapeutics: Betting On A One-Shot Future

Jun 13, 2025, 6:27 PM EDT - 2 months ago

Crispr Therapeutics: Betting On A One-Shot Future

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Jun 9, 2025, 5:50 PM EDT - 2 months ago

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

Jun 3, 2025, 4:07 PM EDT - 3 months ago

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

May 29, 2025, 8:30 AM EDT - 3 months ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

May 9, 2025, 7:14 AM EDT - 3 months ago

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

May 8, 2025, 8:36 AM EDT - 3 months ago

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

May 7, 2025, 4:03 PM EDT - 3 months ago

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

May 7, 2025, 2:17 PM EDT - 3 months ago

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

May 7, 2025, 8:39 AM EDT - 3 months ago

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

May 6, 2025, 4:01 PM EDT - 4 months ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

May 5, 2025, 4:44 AM EDT - 4 months ago

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

NTLA

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

Apr 8, 2025, 3:29 PM EDT - 5 months ago

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 8:00 AM EDT - 5 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics Announces Transition of Chief Operating Officer

Mar 26, 2025, 4:01 PM EDT - 5 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

CRISPR Therapeutics Set To Reach Previous Heights

Mar 25, 2025, 11:03 AM EDT - 5 months ago

CRISPR Therapeutics Set To Reach Previous Heights

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 3, 2025, 3:28 PM EST - 6 months ago

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 26, 2025, 8:00 AM EST - 6 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

Feb 13, 2025, 11:06 AM EST - 6 months ago

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 11, 2025, 4:01 PM EST - 7 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Feb 5, 2025, 4:16 PM EST - 7 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

Feb 5, 2025, 3:48 PM EST - 7 months ago

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

Jan 15, 2025, 7:20 PM EST - 7 months ago

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Jan 14, 2025, 7:39 PM EST - 8 months ago

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 8:30 AM EST - 8 months ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

Dec 29, 2024, 12:56 PM EST - 8 months ago

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

Dec 9, 2024, 12:00 PM EST - 9 months ago

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

Nov 20, 2024, 9:28 PM EST - 9 months ago

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

Nov 15, 2024, 11:37 AM EST - 10 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Nov 14, 2024, 8:30 AM EST - 10 months ago

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

Nov 11, 2024, 12:54 PM EST - 10 months ago

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 9:01 AM EST - 10 months ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Crispr Therapeutics: Poised For A Major Turnaround

Oct 28, 2024, 6:36 AM EDT - 10 months ago

Crispr Therapeutics: Poised For A Major Turnaround

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

Oct 6, 2024, 2:00 PM EDT - 11 months ago

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

AMGN BIIB BLUE BMY EDIT EXAS NTLA

Crispr Therapeutics: Prepare To Be Bored

Sep 18, 2024, 9:11 AM EDT - 1 year ago

Crispr Therapeutics: Prepare To Be Bored

Crispr's Casgevy Launch: Promising Start, Uncertain Future

Aug 14, 2024, 6:08 AM EDT - 1 year ago

Crispr's Casgevy Launch: Promising Start, Uncertain Future

Crispr Therapeutics Q2 Earnings: Casgevy Updates Underline 'Blockbuster' Potential

Aug 7, 2024, 10:41 AM EDT - 1 year ago

Crispr Therapeutics Q2 Earnings: Casgevy Updates Underline 'Blockbuster' Potential

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 5, 2024, 4:01 PM EDT - 1 year ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

Crispr Therapeutics: Beaten Down But Not Broken

Jul 7, 2024, 8:30 AM EDT - 1 year ago

Crispr Therapeutics: Beaten Down But Not Broken

CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript

Jun 11, 2024, 12:32 PM EDT - 1 year ago

CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript

Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)

Jun 10, 2024, 10:27 AM EDT - 1 year ago

Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)

The 'Undercovered' Dozen From June 1-6

Jun 7, 2024, 6:26 PM EDT - 1 year ago

The 'Undercovered' Dozen From June 1-6

ALNY CLOV ENVX GAM HAL LPA PEO

CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)

Jun 6, 2024, 12:40 AM EDT - 1 year ago

CRISPR Therapeutics AG (CRSP) Jefferies 2024 Global Healthcare Conference (Transcript)

shashg
shashg Aug. 27 at 2:30 AM
$ABBV $CRSP $TDOC
1 · Reply
NwordFslur
NwordFslur Aug. 27 at 2:24 AM
$CRSP traumatized by $VKTX, still sticking with CRSP but with shaky hands
0 · Reply
IBott
IBott Aug. 27 at 1:51 AM
$CRSP 165,000 plus more shares bought today by ARK. She can’t stop!
0 · Reply
DimebagDarrell_
DimebagDarrell_ Aug. 26 at 8:23 PM
$CRBU Detached from $CRSP now. Let’s roll.
0 · Reply
BillyBlanks77
BillyBlanks77 Aug. 26 at 7:46 PM
$CRSP Like clockwork. The shorts knock it down at the close on a light volume day. I do think we are due for a 10+% up day with some covering soon...
1 · Reply
AlphaByAI
AlphaByAI Aug. 26 at 6:27 PM
$ABBV $CRSP $TDOC Deep dive in three longevity and aging related stocks. https://newsletter.ai-wk.com/p/longevity-aging-watchlist-abbv-crsp-tdoc
0 · Reply
HodlTurtle
HodlTurtle Aug. 26 at 5:53 PM
$CRSP imagine shorting at the lows after two major insider purchases and institutions stacking at the dips. Who could possibly be that stupid 😂
0 · Reply
svertical1
svertical1 Aug. 26 at 5:22 PM
$IBRX $CADL $CRSP The battle lines are drawn: •On one side, the scum ruthlessly doing everything to protect the decades long monopoly of inevitable failure with chemo & radiation. •Others doing everything to actually make progress towards a cure without destroying a patients natural immunity
2 · Reply
Malachi_Constant
Malachi_Constant Aug. 26 at 4:07 PM
$CRSP every daytrader thinks he's Jeremy Irons in Margin Call. "This is it!" https://www.youtube.com/watch?v=UOYi4NzxlhE
0 · Reply
dileep1209
dileep1209 Aug. 26 at 3:36 PM
$CRSP https://seekingalpha.com/article/4816385-crispr-therapeutics-sell-before-too-late
0 · Reply
Tumble51
Tumble51 Aug. 26 at 2:58 PM
$BEAM $BLUE $CRSP $NTLA $QURE Gee ! I see a true statement hit a nerve Hahaha This is the next Blue Bird Bio
0 · Reply
Tejj
Tejj Aug. 26 at 2:28 PM
$CRSP are we bull flagging or bull trapping.
0 · Reply
Lewis_Vaughan
Lewis_Vaughan Aug. 26 at 2:25 PM
$CRSP I would like to never see 55.00 again please and thank you
0 · Reply
HodlTurtle
HodlTurtle Aug. 26 at 2:21 PM
$CRSP late shorts trapped
0 · Reply
50bps
50bps Aug. 26 at 2:02 PM
$CRSP
0 · Reply
TomMac64
TomMac64 Aug. 26 at 1:40 PM
$BEAM $BLUE $CRSP $NTLA $QURE listen you moron Blue Bird Bio was riddled with debt … BEAM is not in fact Cash to debt ratio is outstanding you are an idiot for even comparing the 2 I could list several more stats but I’m done I can’t believe someone posted this you are a moron !!!!!!!!!!!!
2 · Reply
InItToWinIt100
InItToWinIt100 Aug. 26 at 1:27 PM
Gene-edited pig lung transplanted into a brain-dead patient for the first time $CRSP https://apple.news/AqzNEdXMWTcq9tJNP-peTsQ
0 · Reply
Coconutbeater
Coconutbeater Aug. 26 at 1:19 PM
$CRSP It is not going to go much lower than this. Next quarter and the news coming is going to send us to the next high. Good luck to all.
0 · Reply
stu4
stu4 Aug. 26 at 10:52 AM
$NTLA. Ahhh you poor thing Trolling am I ???? Hardly , just putting out the truth Want those symbols again ??? $BEAM $NTLA $QURE $BLUE ( now private due to failures) $CRSP @Windytimes ahead , blow smoke up every shareholder’s a$$
0 · Reply
SwarmOfDogs
SwarmOfDogs Aug. 26 at 1:00 AM
$CRSP
0 · Reply
IBott
IBott Aug. 26 at 12:41 AM
$CRSP 188,879 more shares bought today by ARK. She won’t give up!
2 · Reply
Coconutbeater
Coconutbeater Aug. 26 at 12:15 AM
$CRSP Anyone waiting. No news is good news. The good news is coming and this will pop real quick.
0 · Reply